ORGO 分类 A Organogenesis Holdings Inc. - Class A
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 6, 2026
$1.33
· % 处于52周区间
· 高于低点
· 至高点
$1.3252周低点
$7.0852周高点
市值 (MRQ)
$171M
P/E (TTM)
-1.7
EPS (TTM)
$-0.79
收入 (TTM)
$457M
ORGO 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.33
市值 (MRQ)
$171M
P/E (TTM)
-1.7
EPS (TTM)
$-0.79
收入 (TTM)
$457M
ROE (TTM)
-44.1%
52周区间
$1–$7
ORGO 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$564M2016-12-31 → 2025-12-31
EPS$0.152018-12-31 → 2025-12-31
自由现金流$-24M2022-12-31 → 2025-12-31
净利率-18.4%2022-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | ORGO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -1.75年均值 ≈-29.5 | ≈-29.5 | · | · | |
| P/S (TTM) | 0.45年均值 ≈1.1 | ≈1.1 | 6.3 | 低估 | |
| 市净率 (MRQ) | 1.25年均值 ≈1.8 | ≈1.8 | 2.1 | 公允价值 | |
| 股价/自由现金流 (TTM) | 8.25年均值 ≈5.4 | ≈5.4 | · | · | |
| 市现率 (TTM) | 5.45年均值 ≈-10.8 | ≈-10.8 | · | · | |
| 市净率（有形资产） (MRQ) | 1.25年均值 ≈2.9 | ≈2.9 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | ORGO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -7.8%5年均值 ≈5.3% | ≈5.3% | -609.2% | 顶尖 | |
| 息税折旧摊销前利润率 (TTM) | -4.4%5年均值 ≈6.2% | ≈6.2% | -576.6% | 顶尖 | |
| 税前利润率 (TTM) | -7.6%5年均值 ≈5.1% | ≈5.1% | -668.6% | 顶尖 | |
| 净利润率 (TTM) | -18.4%5年均值 ≈3.7% | ≈3.7% | -574.5% | 顶尖 | |
| ROA (TTM) | -19.4%5年均值 ≈3.8% | ≈3.8% | -37.9% | 顶尖 | |
| ROE (TTM) | -44.1%5年均值 ≈7.2% | ≈7.2% | -51.0% | 顶尖 | |
| ROIC | 11.7%5年均值 ≈6.8% | ≈6.8% | -63.5% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | ORGO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 3.55年均值 ≈3.1 | ≈3.1 | 11.0 | 低流动性 | |
| Quick Ratio (速动比率) | 3.15年均值 ≈2.7 | ≈2.7 | 10.7 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | ORGO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 17.0%5年均值 ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 7.8%5年均值 ≈5.8% | ≈5.8% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 10.8% | · | · | · | |
| EPS YoY | -66.7%5年均值 ≈72.4% | ≈72.4% | · | · | |
| Net Income YoY (净利润同比增长) | 4201.1%5年均值 ≈882.7% | ≈882.7% | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率（3年）) | 7.7% | · | · | · | |
| EPS CAGR 5Y (每股收益年复合增长率（5年）) | 0.00% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率（3年）) | 33.6%5年均值 ≈-26.5% | ≈-26.5% | · | · | |
| Net Income CAGR 5Y (净利润年复合增长率（5年）) | 16.5% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | ORGO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 1.05年均值 ≈1.0 | ≈1.0 | 0.1 | 顶尖 | |
| Receivables Turnover (应收账款周转率) | 3.45年均值 ≈4.6 | ≈4.6 | · | · | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$660.6K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-11.3%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 6, 2026 | $-0.73 | $-0.36 | -104.5% |
| 2026年3月31日 | 五月 7, 2026 | $-0.41 | $-0.32 | -29.7% |
| 2025年12月31日 | $0.31 | $0.21 | 44.7% | |
| 2025年9月30日 | $0.15 | $0.06 | 167.4% | |
| 2025年6月30日 | $-0.10 | $-0.06 | -73.0% | |
| 2025年3月31日 | $-0.10 | $-0.06 | -73.0% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $564M | $482M | $433M | $451M | $467M | $338M | $261M | $193M | $199M | $139M | |
| Cost of Revenue | · | $116M | $106M | $105M | $114M | $87M | $76M | $69M | $61M | $48M | |
| Gross Profit | · | $366M | $327M | $346M | $353M | $251M | $185M | $125M | $137M | $91M | |
| R&D Expense | $45M | $50M | $44M | $40M | $31M | $20M | $15M | $11M | $9M | $6M | |
| SG&A Expense | $326M | $295M | $270M | $284M | $250M | $204M | $200M | $162M | $134M | $93M | |
| Operating Expenses | $519M | $483M | $421M | $324M | $281M | $224M | $215M | $176M | $143M | $99M | |
| Operating Income | $45M | $-1M | $13M | $22M | $72M | $27M | $-30M | $-52M | $-5M | $-9M | |
| Interest Expense | · | · | $2M | $2M | $7M | $11M | $9M | $11M | $8M | $6M | |
| Interest Income | · | · | · | · | · | · | · | $64.0K | $129.0K | $153.0K | |
| Other Non-op | $-5.0K | $20.0K | $57.0K | $-13.0K | $-13.0K | $97.0K | $13.0K | $162.0K | $-9.0K | $285.0K | |
| Pretax Income | $47M | $-3M | $10M | $20M | $63M | $18M | $-39M | $-65M | $-15M | $-15M | |
| Income Tax | $10M | $-4M | $5M | $5M | $-31M | $530.0K | $150.0K | $84.0K | $-7M | $65.0K | |
| Net Income | $37M | $861.0K | $5M | $16M | $94M | $17M | $-39M | $-65M | $-8M | $-17M | |
| EPS (Basic) | $0.16 | $-0.01 | $0.04 | $0.12 | $0.73 | $0.16 | $-0.42 | $-0.94 | · | · | |
| EPS (Diluted) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 | $0.15 | $-0.42 | $-0.94 | · | · | |
| Shares (Basic) | 126,738,136 | 131,673,278 | 131,231,317 | 130,070,231 | 128,331,022 | 107,737,936 | 92,840,401 | 69,318,456 | · | · | |
| Shares (Diluted) | 130,248,412 | 131,673,278 | 132,746,727 | 132,383,152 | 133,662,659 | 111,360,831 | 92,840,401 | 69,318,456 | · | · | |
| EBITDA | $60M | · | $13M | $22M | · | · | · | · | · | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $94M | $136M | $104M | $102M | $114M | $84M | $60M | $21M | $2M | $1M | |
| Receivables | $217M | $110M | $82M | $89M | $82M | $57M | $39M | $34M | $28M | · | |
| Inventory | $30M | $26M | $28M | $25M | $25M | $28M | $23M | $13M | $14M | · | |
| Prepaid Expense | $18M | $14M | $10M | $5M | $5M | $5M | $3M | $2M | $4M | $395.8K | |
| Current Assets | $362M | $286M | $225M | $223M | $227M | $174M | $126M | $71M | $50M | $1M | |
| PP&E (Net) | $104M | $89M | $116M | $102M | $79M | $56M | $47M | $40M | $42M | · | |
| PP&E (Gross) | $165M | $140M | $130M | $100M | $89M | $88M | $83M | $79M | $79M | · | |
| Accum. Depreciation | $88M | $73M | $73M | $63M | $58M | $74M | $66M | $62M | $59M | · | |
| Goodwill | $29M | $29M | $29M | $29M | $29M | $29M | $26M | $26M | $26M | · | |
| Intangibles | $9M | $12M | $16M | $21M | $26M | $31M | $21M | $26M | $30M | · | |
| Other Non-current Assets | $9M | $5M | $6M | $2M | $2M | $670.0K | $884.0K | $579.0K | $735.0K | · | |
| Total Assets | $599M | $498M | $460M | $449M | $443M | $290M | $221M | $164M | $149M | $311M | |
| Accounts Payable | $32M | $29M | $31M | $32M | $29M | $23M | $28M | $19M | $19M | · | |
| Accrued Liabilities | $50M | $39M | $30M | $26M | $37M | $24M | $23M | $20M | $23M | $50.8K | |
| Short-term Debt | · | · | · | · | · | · | $0 | $3M | $0 | · | |
| Current Liabilities | $100M | $77M | $81M | $75M | $83M | $68M | $60M | $56M | $52M | $478.4K | |
| Capital Leases | $22M | $25M | $25M | $21M | $47M | $0 | $14M | $15M | $12M | · | |
| Other Non-current Liabilities | $1M | $894.0K | $1M | $1M | $2M | $8M | $7M | $6M | $2M | · | |
| Total Liabilities | $165M | $113M | $181M | $184M | $202M | $148M | $165M | $117M | $157M | $11M | |
| Long-term Debt | · | · | $67M | $71M | $74M | $70M | · | · | $52M | · | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $10.0K | $9.0K | $6.0K | · | |
| Paid-in Capital | · | · | · | · | · | $297M | · | · | · | · | |
| Retained Earnings | $-3M | $-40M | $-41M | $-45M | $-61M | $-155M | $-171M | $-130M | $-65M | $-233.9K | |
| Stockholders' Equity | $300M | $263M | $279M | $266M | $241M | $142M | $52M | $40M | $-15M | $-16M | |
| Liabilities + Equity | $599M | $498M | $460M | $449M | $443M | $290M | $221M | $164M | $149M | $311M | |
| Shares Outstanding | 126,951,876 | 125,730,236 | 131,316,396 | 130,919,129 | 128,680,192 | 127,731,833 | 104,870,886 | 91,261,413 | 66,983,139 | 63,872,058 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $14M | $10M | $6M | · | · | · | · | · | · | |
| Stock-based Comp | $13M | $11M | $9M | $7M | $4M | $2M | $936.0K | $1M | $919.0K | $473.0K | |
| Deferred Tax | $10M | $-11M | $2M | $2M | $-32M | $112.0K | $111.0K | $186.0K | $-7M | · | |
| Amort. of Intangibles | $3M | $3M | $5M | $5M | $5M | $4M | $6M | $4M | $2M | $2M | |
| Restructuring | $516.0K | $0 | $4M | $2M | $5M | $618.0K | · | · | · | · | |
| Other Non-cash | $-85M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-10M | $14M | $31M | $25M | $62M | $5M | $-34M | $-61M | $-3M | $-5M | |
| CapEx | $14M | $10M | $24M | $34M | $31M | $18M | $6M | $2M | $2M | $1M | |
| Investing Cash Flow | $-14M | $-10M | $-24M | $-34M | $-31M | $-23M | $-6M | $-2M | $-15M | $-1M | |
| Stock Issued | · | · | · | · | · | $65M | $50M | $92M | · | $304M | |
| Stock Repurchased | · | $25M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $304M | |
| Financing Cash Flow | $-17M | $28M | $-6M | $-2M | $-1M | $42M | $79M | $82M | $19M | $7M | |
| Net Change in Cash | $-42M | $32M | $1M | $-11M | $30M | $24M | $39M | $19M | $500.0K | $659.0K | |
| Taxes Paid | $5M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-24M | · | $7M | $-9M | · | · | · | · | · | · | |
| Levered FCF | · | · | $6M | $-11M | · | · | · | · | · | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 75.4% | 76.7% | · | · | · | · | · | · | |
| Operating Margin | 7.9% | · | 2.9% | 5.0% | · | · | · | · | · | · | |
| Net Margin | 6.6% | · | 1.1% | 3.4% | · | · | · | · | · | · | |
| Pretax Margin | 8.3% | · | 2.4% | 4.5% | · | · | · | · | · | · | |
| EBITDA Margin | 10.6% | · | 2.9% | 5.0% | · | · | · | · | · | · | |
| ROA | 6.8% | · | 1.1% | 3.5% | · | · | · | · | · | -0.13% | |
| ROE | 13.9% | · | 1.8% | 5.9% | · | · | · | · | · | -4.9% | |
| ROIC | 11.7% | · | 2.1% | 6.4% | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | · | 2.8 | 3.0 | · | · | · | · | · | 3.0 | |
| Quick Ratio | 3.1 | · | 2.3 | 2.6 | · | · | · | · | · | 2.2 | |
| Interest Coverage | · | · | 5.7 | 11.1 | · | · | · | · | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | · | 1.0 | 1.0 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | · | 4.0 | 4.2 | · | · | · | · | · | · | |
| Receivables Turnover | 3.4 | · | 5.1 | 5.2 | · | · | · | · | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.36 | · | $2.12 | $2.03 | · | · | · | · | · | $0.54 | |
| Revenue / Share | $4.33 | · | $3.26 | $3.41 | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.08 | · | $0.23 | $0.19 | · | · | · | · | · | · | |
| Cash / Share | $0.74 | · | $0.79 | $0.78 | · | · | · | · | · | $0.11 | |
| EPS (TTM) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 | $0.15 | $-0.42 | $-0.94 | $-0.13 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 17.0% | 11.3% | -3.9% | -3.5% | 38.1% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.8% | 1.0% | 8.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.8% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -66.7% | -82.9% | 366.7% | · | · | · | · | · | |
| EPS CAGR 3Y | 7.7% | · | -35.6% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 0.00% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 4201.1% | -82.6% | -68.2% | -83.5% | 446.6% | · | · | · | · | · | |
| Net Income CAGR 3Y | 33.6% | -79.1% | -34.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 16.5% | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $564M | $482M | $433M | $451M | $467M | $338M | $261M | $193M | $199M | $139M | |
| Net Income TTM | $37M | $861.0K | $5M | $16M | $94M | $17M | $-39M | $-65M | $-8M | $-17M | |
| Market Cap | $658M | · | $537M | $352M | · | · | · | · | · | · | |
| P/E | 34.5 | -320.0 | 102.2 | 22.4 | 13.2 | 50.2 | -11.5 | -10.8 | -76.3 | · | |
| P/S | 1.2 | · | 1.2 | 0.8 | · | · | · | · | · | · | |
| P/B | 2.2 | · | 1.9 | 1.3 | · | · | · | · | · | · | |
| P / Tangible Book | 2.5 | 1.8 | 2.3 | 1.6 | 6.4 | 11.7 | · | · | · | · | |
| P / Cash Flow | -63.8 | · | 17.4 | 14.2 | · | · | · | · | · | · | |
| P / FCF | -26.9 | · | 82.0 | -39.0 | · | · | · | · | · | · | |
| Earnings Yield | 2.9% | -0.31% | 0.98% | 4.5% | 7.6% | 2.0% | -8.7% | -9.3% | -1.3% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44M | $37M | $226M | $151M | $101M | $87M | $127M | $115M | $130M | $110M | $100M | $109M | $117M | $108M | $116M | $117M | |
| Cost of Revenue | · | · | · | · | · | $24M | · | $27M | $29M | $29M | · | $26M | $26M | $27M | $27M | $26M | |
| Gross Profit | · | · | · | · | · | $63M | · | $88M | $101M | $81M | · | $83M | $91M | $81M | $88M | $91M | |
| R&D Expense | $18M | $15M | $10M | $13M | $10M | $11M | $12M | $10M | $16M | $13M | $12M | $10M | $11M | $11M | $11M | $10M | |
| SG&A Expense | $54M | $65M | $100M | $80M | $74M | $73M | $74M | $72M | $77M | $72M | $61M | $64M | $70M | $74M | $68M | $79M | |
| Operating Expenses | $95M | $106M | $186M | $130M | $114M | $113M | $145M | $109M | $144M | $85M | $180M | $75M | $81M | $85M | $80M | $89M | |
| Operating Income | $-51M | $-69M | $63M | $21M | $-13M | $-27M | $10M | $6M | $-14M | $-4M | $-1M | $8M | $10M | $-4M | $9M | $2M | |
| Interest Expense | · | · | · | · | · | · | · | · | $620.0K | $514.0K | · | $444.0K | $594.0K | $649.0K | · | $572.0K | |
| Other Non-op | $-26.0K | $38.0K | $-98.0K | $18.0K | $73.0K | $2.0K | $-27.0K | $52.0K | $-28.0K | $23.0K | $-25.0K | $31.0K | $28.0K | $23.0K | $6.0K | $5.0K | |
| Pretax Income | $-51M | $-68M | $63M | $21M | $-12M | $-26M | $10M | $6M | $-15M | $-4M | $-2M | $8M | $9M | $-5M | $9M | $1M | |
| Income Tax | $45M | $-15M | $20M | $-407.0K | $-2M | $-7M | $3M | $-7M | $3M | $-2M | $-1M | $4M | $4M | $-2M | $1M | $997.0K | |
| Net Income | $-96M | $-53M | $44M | $22M | $-9M | $-19M | $8M | $12M | $-17M | $-2M | $-569.0K | $3M | $5M | $-3M | $7M | $215.0K | |
| EPS (Basic) | $-0.77 | $-0.44 | $0.32 | $0.11 | $-0.10 | $-0.17 | $0.05 | $0.09 | $-0.13 | $-0.02 | $0.00 | $0.02 | $0.04 | $-0.02 | $0.06 | $0.00 | |
| EPS (Diluted) | $-0.77 | $-0.44 | $0.31 | $0.11 | $-0.10 | $-0.17 | $0.05 | $0.09 | $-0.13 | $-0.02 | $0.00 | $0.02 | $0.04 | $-0.02 | $0.06 | $0.00 | |
| Shares (Basic) | 128,674,548 | 127,797,013 | · | 126,881,709 | 126,853,536 | 126,295,642 | · | 132,575,301 | 132,573,153 | 131,861,772 | · | 131,312,483 | 131,293,398 | 131,083,841 | · | 130,903,160 | |
| Shares (Diluted) | 128,674,548 | 127,797,013 | · | 130,848,995 | 126,853,536 | 126,295,642 | · | 133,926,755 | 132,573,153 | 131,861,772 | · | 133,417,721 | 133,066,010 | 131,083,841 | · | 132,232,954 | |
| EBITDA | $-51M | $-65M | · | $21M | $-13M | $-23M | · | $10M | $-11M | $-4M | · | $8M | $10M | $-4M | · | $2M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $91M | $94M | $64M | $73M | $110M | $136M | $94M | $90M | $89M | · | $98M | $89M | $89M | · | $107M | |
| Receivables | $101M | $117M | $217M | $169M | $120M | $103M | $110M | $101M | $106M | $96M | · | $89M | $94M | $92M | · | $93M | |
| Inventory | $29M | $28M | $30M | $40M | $33M | $29M | $26M | $27M | $27M | $28M | · | $28M | $25M | $26M | · | $25M | |
| Prepaid Expense | $20M | $29M | $18M | $23M | $28M | $18M | $14M | $15M | $11M | $14M | · | $10M | $8M | $10M | · | $5M | |
| Current Assets | $200M | $269M | $362M | $300M | $260M | $268M | $286M | $239M | $234M | $227M | · | $226M | $216M | $217M | · | $231M | |
| PP&E (Net) | $102M | $104M | $104M | $78M | $76M | $76M | $89M | $90M | $90M | $114M | · | $118M | $112M | $107M | · | $97M | |
| PP&E (Gross) | · | · | $165M | $135M | $132M | $128M | $140M | $144M | $146M | $131M | · | $128M | $119M | $116M | · | $99M | |
| Accum. Depreciation | · | · | $88M | $84M | $80M | $76M | $73M | $75M | $75M | $75M | · | $70M | $68M | $65M | · | $62M | |
| Goodwill | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | · | $29M | $29M | $29M | · | $29M | |
| Intangibles | $3M | $3M | $9M | $10M | $11M | $12M | $12M | $13M | $14M | $15M | · | $17M | $18M | $20M | · | $22M | |
| Other Non-current Assets | $23M | $16M | $9M | $14M | $9M | $6M | $5M | $5M | $6M | $7M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $406M | $520M | $599M | $510M | $461M | $467M | $498M | $446M | $443M | $458M | · | $463M | $450M | $446M | · | $457M | |
| Accounts Payable | $29M | $29M | $32M | $40M | $30M | $25M | $29M | $24M | $29M | $23M | · | $27M | $27M | $30M | · | $38M | |
| Accrued Liabilities | · | · | $50M | $40M | $26M | $31M | $39M | $36M | $38M | $40M | · | $35M | $28M | $29M | · | $34M | |
| Current Liabilities | $57M | $76M | $100M | $90M | $66M | $65M | $77M | $77M | $86M | $83M | · | $81M | $73M | $76M | · | $89M | |
| Capital Leases | $21M | $22M | $22M | $24M | $25M | $26M | $25M | $23M | $23M | $24M | · | $39M | $40M | $40M | · | $43M | |
| Other Non-current Liabilities | $4M | $1M | $1M | $3M | $3M | $897.0K | $894.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $118M | $139M | $165M | $124M | $100M | $99M | $113M | $168M | $180M | $180M | · | $186M | $179M | $182M | · | $201M | |
| Long-term Debt | · | · | · | · | · | · | · | $62M | $64M | $65M | · | $68M | $69M | $70M | · | $73M | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | · | $13.0K | $13.0K | $13.0K | · | $13.0K | |
| Retained Earnings | $-153M | $-56M | $-3M | $-47M | $-68M | $-59M | $-40M | $-48M | $-60M | $-43M | · | $-40M | $-44M | $-49M | · | $-53M | |
| Stockholders' Equity | $148M | $245M | $300M | $255M | $233M | $243M | $263M | $279M | $264M | $278M | $279M | $277M | $271M | $264M | $266M | $256M | |
| Liabilities + Equity | $406M | $520M | $599M | $510M | $461M | $467M | $498M | $446M | $443M | $458M | · | $463M | $450M | $446M | · | $457M | |
| Shares Outstanding | 128,674,548 | 128,674,548 | 126,951,876 | 126,911,442 | 126,853,536 | 126,853,536 | 125,730,236 | 132,576,502 | 132,574,238 | 132,539,340 | 131,316,396 | 131,312,616 | 131,311,852 | 131,226,387 | 130,919,129 | 130,915,099 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | · | · | · | |
| Stock-based Comp | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | $45M | $-15M | $16M | $-4M | $-1M | $-1M | $-3M | $-2M | · | · | $2M | · | · | · | · | · | |
| Amort. of Intangibles | $433.0K | $6M | $798.0K | $842.0K | $841.0K | $842.0K | $834.0K | $834.0K | $834.0K | $901.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $96.0K | $-126.0K | $2M | $750.0K | $611.0K | |
| Other Non-cash | · | $82M | · | · | · | $-7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-32M | $21M | $39M | $3M | $-33M | $-20M | $11M | $9M | $5M | $-10M | $11M | $17M | $9M | $-5M | $8M | $5M | |
| CapEx | $1M | $3M | $5M | $2M | $4M | $4M | $3M | $3M | $2M | $2M | $3M | $6M | $7M | $8M | $11M | $10M | |
| Investing Cash Flow | $-1M | $-3M | $-5M | $-2M | $-4M | $-4M | $-3M | $-3M | $-2M | $-2M | $-3M | $-6M | $-7M | $-8M | $-11M | $-10M | |
| Financing Cash Flow | $-13M | $-20M | $-5M | $-10M | $-288.0K | $-2M | $34M | $-2M | $-2M | $-3M | $-2M | $-1M | $-1M | $-1M | $-2M | $26.0K | |
| Net Change in Cash | $-45M | $-2M | $30M | $-9M | $-37M | $-26M | $41M | $4M | $1M | $-15M | $6M | $9M | $93.0K | $-14M | $-5M | $-5M | |
| Free Cash Flow | · | $18M | · | · | · | $-24M | · | · | · | $-12M | · | · | · | $-13M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | · | $-13M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 72.6% | · | 76.7% | 77.6% | 73.9% | · | 76.2% | 77.6% | 75.3% | · | 77.6% | |
| Operating Margin | -116.5% | -185.1% | · | 13.7% | -12.4% | -30.9% | · | 5.4% | -10.7% | -3.5% | · | 7.4% | 8.3% | -3.7% | · | 1.5% | |
| Net Margin | -220.0% | -142.8% | · | 14.3% | -9.3% | -21.7% | · | 10.7% | -13.1% | -1.9% | · | 2.9% | 4.5% | -2.8% | · | 0.18% | |
| Pretax Margin | -116.3% | -183.9% | · | 14.0% | -11.7% | -29.7% | · | 5.1% | -11.2% | -4.0% | · | 7.0% | 7.8% | -4.3% | · | 1.0% | |
| EBITDA Margin | -116.5% | -173.8% | · | 13.7% | -12.4% | -26.9% | · | 8.5% | -8.1% | -3.5% | · | 7.4% | 8.3% | -3.7% | · | 1.5% | |
| ROA | -22.2% | -10.8% | · | 4.5% | -2.1% | -4.1% | · | 2.7% | -3.8% | -0.46% | · | 0.69% | 1.2% | -0.67% | · | 0.05% | |
| ROE | -50.5% | -21.8% | · | 8.1% | -3.8% | -7.2% | · | 4.4% | -6.4% | -0.78% | · | 1.2% | 2.0% | -1.2% | · | 0.10% | |
| ROIC | -65.1% | -21.9% | · | 8.3% | -4.3% | -8.1% | · | 4.8% | -6.2% | -0.67% | · | 1.2% | 2.1% | -0.97% | · | 0.12% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.5 | · | 3.3 | 4.0 | 4.1 | · | 3.1 | 2.7 | 2.7 | · | 2.8 | 2.9 | 2.9 | · | 2.6 | |
| Quick Ratio | 2.6 | 2.7 | · | 2.6 | 2.9 | 3.3 | · | 2.5 | 2.3 | 2.2 | · | 2.3 | 2.5 | 2.4 | · | 2.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -22.4 | -7.5 | · | 18.1 | 16.4 | -6.2 | · | 3.1 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.3 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Inventory Turnover | · | · | · | · | · | 0.8 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | |
| Receivables Turnover | 0.4 | 0.3 | · | 1.1 | 0.9 | 0.9 | · | 1.2 | 1.3 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.4 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.15 | $1.90 | · | $2.01 | $1.84 | $1.91 | · | $2.10 | $1.99 | $2.10 | · | $2.11 | $2.07 | $2.01 | · | $1.96 | |
| Revenue / Share | $0.34 | $0.29 | · | $1.15 | $0.80 | $0.69 | · | $0.86 | $0.98 | $0.83 | · | $0.81 | $0.88 | $0.82 | · | $0.88 | |
| Cash Flow / Share | · | $0.17 | · | · | · | $-0.16 | · | · | · | $-0.08 | · | · | · | $-0.04 | · | · | |
| Cash / Share | $0.36 | $0.71 | · | $0.50 | $0.58 | $0.87 | · | $0.71 | $0.68 | $0.67 | · | $0.75 | $0.68 | $0.68 | · | $0.82 | |
| EPS (TTM) | $-0.79 | $-0.12 | · | $-0.11 | $-0.13 | $-0.16 | · | $-0.06 | $-0.13 | $0.04 | · | $0.10 | $0.08 | $0.11 | · | $0.45 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $457M | $515M | · | $465M | $430M | $459M | · | $455M | $448M | $435M | · | $449M | $457M | $461M | · | $463M | |
| Net Income TTM | $-84M | $3M | · | $1M | $-8M | $-16M | · | $-7M | $-17M | $6M | · | $13M | $10M | $13M | · | $59M | |
| Market Cap | $313M | $305M | · | $536M | $464M | $548M | · | $379M | $371M | $376M | · | $418M | $436M | $280M | · | $424M | |
| P/E | -3.1 | -19.8 | · | -38.4 | -28.2 | -27.0 | · | -47.7 | -21.5 | 71.0 | · | 31.8 | 41.5 | 19.4 | · | 7.2 | |
| P/S | 0.7 | 0.6 | · | 1.2 | 1.1 | 1.2 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 1.0 | 0.6 | · | 0.9 | |
| P/B | 2.1 | 1.2 | · | 2.1 | 2.0 | 2.3 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.1 | · | 1.7 | |
| P / Tangible Book | 2.7 | 1.4 | · | 2.5 | 2.4 | 2.7 | · | 1.6 | 1.7 | 1.6 | · | 1.8 | 1.9 | 1.3 | · | 2.1 | |
| P / Cash Flow | · | 14.4 | · | · | · | -27.5 | · | · | · | -37.0 | · | · | · | -55.1 | · | · | |
| Earnings Yield | -32.5% | -5.1% | · | -2.6% | -3.5% | -3.7% | · | -2.1% | -4.6% | 1.4% | · | 3.1% | 2.4% | 5.2% | · | 13.9% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $564M | $482M | $433M | $451M | $467M |
| 毛利率 % | · | · | 75.4% | 76.7% | · |
| 营业利润率 % | 7.9% | · | 2.9% | 5.0% | · |
| 净收入 | $37M | $861.0K | $5M | $16M | $94M |
| 稀释后每股收益 (EPS) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 3.6 | · | 2.8 | 3.0 | · |
| 速动比率 | 3.1 | · | 2.3 | 2.6 | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-24M | · | $7M | $-9M | · |
机构持有人 (13F) 140 家申报者 · $179.8M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
140
持有价值
$179.8M
新仓位
32
已退出持仓
14
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 32 (+14 与上一季度对比) | 14 (-26 与上一季度对比) | 52 (+20 与上一季度对比) | 33 (-13 与上一季度对比) | +4.5M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| MORGAN STANLEY | $28483510 | 11721609 | 15.84% | 股份 |
| VANGUARD GROUP INC | $25686978 | 4958876 | 14.28% | 股份 |
| Soleus Capital Management, L.P. | $24642511 | 10140951 | 13.70% | 股份 |
| BlackRock, Inc. | $17616354 | 7249528 | 9.80% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $7412123 | 3050297 | 4.12% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $7318559 | 3011753 | 4.07% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $7061383 | 2905919 | 3.93% | 股份 |
| D. E. Shaw & Co., Inc. | $7018601 | 2888313 | 3.90% | 股份 |
| Assenagon Asset Management S.A. | $4782123 | 1967952 | 2.66% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $4704612 | 1935554 | 2.62% | 股份 |
| DEUTSCHE BANK AG\ | $4146032 | 1706186 | 2.31% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3906781 | 1607729 | 2.17% | 股份 |
| STATE STREET CORP | $3693491 | 1519955 | 2.05% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $2471585 | 1017113 | 1.37% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2199208 | 905024 | 1.22% | 股份 |
| GOLDMAN SACHS GROUP INC | $2156380 | 887399 | 1.20% | 股份 |
| CITADEL ADVISORS LLC | $2109067 | 867929 | 1.17% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1682039 | 692197 | 0.94% | 股份 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $1527741 | 628700 | 0.85% | 股份 |
| NORTHERN TRUST CORP | $1420522 | 584577 | 0.79% | 股份 |
| BANK OF AMERICA CORP /DE/ | $1368206 | 563048 | 0.76% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $1336500 | 550000 | 0.74% | 股份 |
| NORGES BANK | $1290087 | 530900 | 0.72% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $1203732 | 495363 | 0.67% | 股份 |
| FLAX POND CAPITAL, LLC | $1026896 | 422591 | 0.57% | 股份 |
| UBS Group AG | $871661 | 358708 | 0.48% | 股份 |
| Bank of New York Mellon Corp | $776732 | 319643 | 0.43% | 股份 |
| MERCER GLOBAL ADVISORS INC /ADV | $755154 | 310763 | 0.42% | 股份 |
| Squarepoint Ops LLC | $613881 | 252626 | 0.34% | 股份 |
| ExodusPoint Capital Management, LP | $556067 | 228834 | 0.31% | 股份 |
| FMR LLC | $523944 | 215615 | 0.29% | 股份 |
| VOYA INVESTMENT MANAGEMENT LLC | $498667 | 205213 | 0.28% | 股份 |
| Nuveen, LLC | $469488 | 193205 | 0.26% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $454354 | 186977 | 0.25% | 股份 |
| XTX Topco Ltd | $446537 | 183760 | 0.25% | 股份 |
| Vanguard Global Advisers, LLC | $419586 | 172669 | 0.23% | 股份 |
| Invesco Ltd. | $410437 | 168904 | 0.23% | 股份 |
| BARCLAYS PLC | $394780 | 162461 | 0.22% | 股份 |
| Wealth Dimensions Group, Ltd. | $369968 | 152250 | 0.21% | 股份 |
| Mariner, LLC | $358977 | 147731 | 0.20% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $351769 | 144761 | 0.20% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $351518 | 148320 | 0.20% | 股份 |
| HSBC HOLDINGS PLC | $323561 | 139166 | 0.18% | 股份 |
| Cerity Partners LLC | $310018 | 127579 | 0.17% | 股份 |
| AMERIPRISE FINANCIAL INC | $239445 | 98537 | 0.13% | 股份 |
| RHUMBLINE ADVISERS | $208147 | 85660 | 0.12% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $205943 | 84750 | 0.11% | 股份 |
| Creative Planning | $205160 | 84428 | 0.11% | 股份 |
| State of Wyoming | $203738 | 83843 | 0.11% | 股份 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $181577 | 75657 | 0.10% | 股份 |
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Glenn H. Nussdorf, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 | 2025年11月3日 | 9.70% | 修订 | · | SEC |
| Alan A. Ades, Albert Erani, Glenn H. Nussdorf, Dennis Erani, Starr Wisdom, Organo PFG LLC, Organo Investors LLC, Alan Ades 2014 GRAT, Albert Erani Family Trust dated 12/29/2012, Dennis Erani 2012 Issue Trust dated 12/20/12, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016, RED Holdings, LLC, Josette Ades ×11 申报 | 2025年6月26日 | 17.60% | 修订 | · | SEC |
| Avista Healthcare Partners III, L.P., AHP III Orchestra Holdings, L.P., Avista Capital Partners VI GP, L.P., Avista Capital Managing Member VI, LLC, Thompson Dean, David Burgstahler | 2024年11月19日 | · | 初始申报 | 被动投资 | SEC |
| Avista Acquisition Corp., Avista Acquisition, LLC, Avista Capital Partners (Offshore) IV, LP, Avista Capital Partners IV, L.P., Avista Capital Managing Member IV, LLC, Avista Capital Partners IV GP L.P., Thompson Dean, David Burgstahler ×6 申报 | 2021年5月27日 | · | 初始申报 | · | SEC |
| Avista Acquisition Corp. (2), Avista Acquisition, LLC. (2), Avista Capital Partners (Offshore) IV, LP (2), Avista Capital Partners IV, L.P. (2), Avista Capital Managing Member IV, LLC (2), Avista Capital Partners, IV GP L.P. (2), Thompson Dean (2), David Burgstahler (2) | 2018年12月20日 | · | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 27 位内幕人士 · 10 位高管 · 15 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Gary S. Gillheeney | President and CEO | 2026年2月18日 F | 4232087 | 0 | 0 | $0 |
| David Francisco | Chief Financial Officer | 2026年2月18日 F | 731312 | 0 | 0 | $0 |
| Henry Hagopian III | Interim CFO | 2021年1月13日 A | 12073 | 0 | 0 | $0 |
| Timothy M. Cunningham | Chief Financial Officer | 2020年4月22日 A | 27847 | 0 | 0 | $0 |
| Patrick Bilbo | Chief Operating Officer | 2026年2月18日 F | 1128312 | 0 | 0 | $0 |
| Robert Cavorsi | Vice President, Strategy | 2026年3月1日 F | 275524 | 0 | 0 | $0 |
| Antonio S. Montecalvo | Vice President, Health Policy | 2026年2月18日 F | 226238 | 0 | 0 | $0 |
| Lori Freedman | Chief Admin. and Legal Officer | 2026年2月18日 F | 1023643 | 0 | 0 | $0 |
| Brian Grow | Chief Commercial Officer | 2025年1月10日 M | 900682 | 0 | 0 | $0 |
| Howard Walthall | Exec. VP, Strat. & Mkt Dev. | 2018年12月10日 A | · | 0 | 0 | $0 |
| Michael Joseph Driscoll | 董事 | 2026年3月9日 P | 225707 | 1 | 0 | $26700 |
| Arthur S Leibowitz | 董事 | 2026年3月9日 P | 291014 | 1 | 0 | $13400 |
| Garrett Lustig | 董事 | 2026年2月18日 A | 125742 | 0 | 0 | $0 |
| Gilberto Quintero | 董事 | 2026年2月18日 A | 239073 | 0 | 0 | $0 |
| Prathyusha Duraibabu | 董事 | 2026年2月18日 A | 247047 | 0 | 0 | $0 |
| Michele Ilene Korfin | 董事 | 2026年2月18日 A | 239073 | 0 | 0 | $0 |
| Jon L Giacomin | 董事 | 2026年2月18日 A | 241026 | 0 | 0 | $0 |
| Glenn H. Nussdorf | 董事 | 2025年12月16日 S | 2565591 | 2 | 6 | $-1603954 |
| Joshua Alexander Tamaroff | 董事 | 2021年2月16日 A | 30364 | 0 | 0 | $0 |
| Wayne D Mackie | 董事 | 2021年2月16日 A | 211800 | 0 | 0 | $0 |
| Robert P O'Neil | 董事 | 2018年12月10日 D | · | 0 | 0 | $0 |
| Charles C Harwood Jr | 董事 | 2018年12月10日 D | · | 0 | 0 | $0 |
| Hakan Bjorklund | 董事 | 2018年12月10日 D | · | 0 | 0 | $0 |
| Brian A Markison | 董事 | 2018年12月10日 D | · | 0 | 0 | $0 |
| Michael W Katz | 10% 所有者 | 2022年11月21日 P | 76382 | 0 | 0 | $0 |
| Dennis Erani | 10% 所有者 | 2021年5月27日 S | 1314517 | 0 | 0 | $0 |
| Starr Wisdom | 10% 所有者 | 2021年4月9日 S | 20000 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 22 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| VFQY · VANGUARD WELLINGTON FUND | 0.03% | 49635 SH | 2026年8月19日 | 每日 |
| IWC · iShares Trust | 0.03% | 239111 SH | 2026年9月11日 | 每日 |
| VFVA · VANGUARD WELLINGTON FUND | 0.02% | 79308 SH | 2026年8月19日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 396742 SH | 2026年8月19日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 60177 SH | 2026年8月19日 | 每日 |
| DFSV · Dimensional ETF Trust | 0.01% | 267878 NS | 2026年7月31日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 129858 SH | 2026年10月2日 | 每日 |
| RSSL · Global X Funds | 0.01% | 33027 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 295905 NS | 2026年7月31日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.00% | 221009 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.00% | 1771226 SH | 2026年9月11日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.00% | 4647 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 205812 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 9772 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 22383 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 31880 SH | 2026年9月9日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.00% | 9630 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 848524 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1991446 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 5493 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.00% | 189815 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 625359 SH | 2026年9月11日 | 每日 |
ORGO 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 7 位分析师
卖出
中位数目标
$2.00
+50.4%
0 0.0%
强烈买入
0 0.0%
买入
4 57.1%
持有
1 14.3%
卖出
2 28.6%
强烈卖出
12个月价格目标
1 位分析师 · 2026-10-04平均目标 $2.00 +50.4%
最低$2.00
平均值$2.00
最高$2.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| AVXL | · | -16.5 | -36.1% | -991.4% | · | · |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| CMPX | $958M | · | · | · | -45.9% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 6, 2026 申报